Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Privia Health (PRVA) Cash from Financing Activities (2020 - 2025)

Privia Health has reported Cash from Financing Activities over the past 6 years, most recently at $2.1 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at $2.1 million for Q4 2025, up 246.53% from a year ago — trailing twelve months through Dec 2025 was $6.7 million (up 54.64% YoY), and the annual figure for FY2025 was $6.7 million, up 54.64%.
  • Cash from Financing Activities for Q4 2025 was $2.1 million at Privia Health, up from $431000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for PRVA hit a ceiling of $210.8 million in Q2 2021 and a floor of -$30.9 million in Q2 2022.
  • Median Cash from Financing Activities over the past 5 years was $1.5 million (2023), compared with a mean of $10.4 million.
  • Biggest five-year swings in Cash from Financing Activities: soared 48229.91% in 2021 and later tumbled 114.66% in 2022.
  • Privia Health's Cash from Financing Activities stood at $3.2 million in 2021, then plummeted by 38.15% to $2.0 million in 2022, then crashed by 97.85% to $42000.0 in 2023, then surged by 1373.81% to $619000.0 in 2024, then surged by 246.53% to $2.1 million in 2025.
  • The last three reported values for Cash from Financing Activities were $2.1 million (Q4 2025), $431000.0 (Q3 2025), and $1.9 million (Q2 2025) per Business Quant data.